Skip to main content

Levocarnitine Side Effects

Medically reviewed by Drugs.com. Last updated on Feb 23, 2025.

Applies to levocarnitine: capsule, capsule liquid filled, solution, tablet.

Serious side effects of levocarnitine

Along with its needed effects, levocarnitine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor as soon as possible if any of the following side effects occur while taking levocarnitine:

More common side effects

Less common side effects

Rare side effects

  • seizures

Other side effects of levocarnitine

Some side effects of levocarnitine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common side effects

Less common side effects

  • abdominal discomfort
  • body odor
  • depression
  • dizziness
  • impaired vision
  • loss of appetite or weight
  • swelling in hands, lower legs, and feet
  • tingling sensation
  • weakness

For healthcare professionals

Applies to levocarnitine: injectable solution, oral capsule, oral solution, oral tablet.

Gastrointestinal adverse events

Nervous system

Metabolic

There are reports from clinical trials of significant hypertriglyceridemia associated with high doses of levocarnitine (3 g/day) given to uremic dialysis patients.[Ref]

Other

Local

Musculoskeletal

Musculoskeletal side effects, in chronic hemodialysis patients, for levocarnitine in relation to placebo therapy have included asthenia (8% to 12% vs 8%) and leg cramps (4% to 8% vs 13%). Mild myasthenia has occurred in uremic patients receiving D,L-carnitine (but not levocarnitine).[Ref]

Hematologic

There have been reports from clinical trials of significant increases in platelet aggregation associated with high doses of levocarnitine (3 g/day) given to hemodialysis patients.[Ref]

Renal

Endocrine

Respiratory

Dermatologic

Ocular

Genitourinary

Cardiovascular

Hypersensitivity

Psychiatric

Immunologic

References

1. (2001) "Product Information. Carnitor (levocarnitine)." Sigma-Tau Pharmaceuticals

2. (2022) "Product Information. LevOCARNitine (levOCARNitine)." Hi-Tech Pharmacal Company Inc

3. Golper TA, Wolfson M, Ahmad S, Hirschberg R, Kurtin P, Katz LA, Nicora R, Ashbrook D, Kopple JD (1990) "Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects." Kidney Int, 38, p. 904-11

4. Lacour B, Di Giulio S, Chanard J, Ciancioni C, Haguet M, Lebkiri B, Basile C, Drueke T, Assan R, Funck-Brentano JL (1980) "Carnitine improves lipid anomalies in haemodialysis patients." Lancet, 2, p. 763-4

5. Weschler A, Aviram M, Levin M, Better OS, Brook JG (1984) "High dose of L-carnitine increases platelet aggregation and plasma triglyceride levels in uremic patients on hemodialysis." Nephron, 38, p. 120-4

6. Bellinghieri G, Savica V, Barbera CM, Ricciardi B, Egitto M, Torre F, Valentini G, D'Iddio S, Bagiella E, Mallamace A, et al. (1990) "L-carnitine and platelet aggregation in uremic patients subjected to hemodialysis." Nephron, 55, p. 28-32

Further information

Levocarnitine side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.